Magic mushrooms could help reduce depression symptoms, study says

Combined ShapeCaption
Magic mushrooms could help with depression, a report says. Researchers tested depressed people with psilocybin. Psilocybin is the psychoactive in magic mushrooms. Patients given psilocybin showed reduced depression symptoms Researchers caution depressed people should not self-medicate. As with all studies, these results are not absolute and more research is needed.

Need help dealing with depression? Magic mushrooms might do the trick, according to a new report.

» RELATED: Magic mushrooms are 'safest drugs' for recreational use, scientists say

Researchers from Imperial College London recently conducted an experiment, published in Scientific Reports, to determine how psilocybin, the psychoactive compound in magic mushrooms, can treat depression.

To do so, scientists rounded up 20 patients “with treatment-resistant form of the disorder,” the authors said. They then gave them a 10 mg dose of psilocybin and a 25 mg dose one week later.

The subjects also underwent brain imaging, which measured changes in blood flow and signals transmitted between brain regions.

Immediately after the treatment, patients reported a decrease in depressive symptoms.

"We have shown for the first time clear changes in brain activity in depressed people treated with psilocybin after failing to respond to conventional treatments," lead author Robin Carhart-Harris said in a statement. "Several of our patients described feeling 'reset' after the treatment and often used computer analogies."

» RELATED: What do magic mushrooms do to your body and brain? 

The brain imaging also revealed reduced blood flow in areas of the brain associated with emotional responses, stress and anxiety.

"Based on what we know from various brain imaging studies with psychedelics, as well as taking heed of what people say about their experiences, it may be that psychedelics do indeed ‘reset’ the brain networks associated with depression, effectively enabling them to be lifted from the depressed state," Carhart-Harris said.

Despite their findings, researchers said people who suffer from depression should not self-medicate.

While they hope to do more research in the future, they say their results thus far are encouraging.

“Through collecting these imaging data,” Carhart-Harris said, “we have been able to provide a window into the after effects of psilocybin treatment in the brains of patients with chronic depression.”

» RELATED: Hallucinogenic mushroom vote could make magic ‘shrooms’ party option if ballot passes